Post-approval studies (Phase 4)Ended earlyNCT03119012
What this trial is testing
P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold
Who this might be right for
Coronary Artery DiseaseStentsAtherosclerosis
Samsung Medical Center 25